| 1. |
|
|
| 2. |
- Bousquet, J., et al.
(författare)
-
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
- 2016
-
Ingår i: Clinical and Translational Allergy. - : Wiley. - 2045-7022. ; 6:1, s. 1-18
-
Forskningsöversikt (refereegranskat)abstract
- Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.
|
|
| 3. |
- Massart, Annick, et al.
(författare)
-
The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients
- 2016
-
Ingår i: Nephrology, Dialysis and Transplantation. - : Oxford University Press (OUP). - 0931-0509 .- 1460-2385. ; 31:6, s. 1002-1013
-
Tidskriftsartikel (refereegranskat)abstract
- Background. Kidney recipients maintaining a prolonged allograft survival in the absence of immunosuppressive drugs and without evidence of rejection are supposed to be exceptional. The ERA-EDTA-DESCARTES working group together with Nantes University launched a European-wide survey to identify new patients, describe them and estimate their frequency for the first time. Methods. Seventeen coordinators distributed a questionnaire in 256 transplant centres and 28 countries in order to report as many 'operationally tolerant' patients (TOL; defined as having a serum creatinine <1.7 mg/dL and proteinuria <1 g/day or g/g creatinine despite at least 1 year without any immunosuppressive drug) and 'almost tolerant' patients (minimally immunosuppressed patients (MIS) receiving low-dose steroids) as possible. We reported their number and the total number of kidney transplants performed at each centre to calculate their frequency. Results. One hundred and forty-seven questionnaires were returned and we identified 66 TOL (61 with complete data) and 34 MIS patients. Of the 61 TOL patients, 26 were previously described by the Nantes group and 35 new patients are presented here. Most of them were noncompliant patients. At data collection, 31/35 patients were alive and 22/31 still operationally tolerant. For the remaining 9/31, 2 were restarted on immunosuppressive drugs and 7 had rising creatinine of whom 3 resumed dialysis. Considering all patients, 10-year death-censored graft survival post-immunosuppression weaning reached 85% in TOL patients and 100% in MIS patients. With 218 913 kidney recipients surveyed, cumulative incidences of operational tolerance and almost tolerance were estimated at 3 and 1.5 per 10 000 kidney recipients, respectively. Conclusions. In kidney transplantation, operational tolerance and almost tolerance are infrequent findings associated with excellent long-term death-censored graft survival.
|
|
| 4. |
- Torres Sánchez, Sonia Alejandra, et al.
(författare)
-
Magmatic source and metamorphic grade of metavolcanic rocks from the Granjeno Schist : Was northeastern Mexico a part of Pangaea?
- 2016
-
Ingår i: Geological Journal. - : Wiley. - 0072-1050. ; 51:6, s. 845-863
-
Tidskriftsartikel (refereegranskat)abstract
- The geochemistry of the metavolcanic rocks from the Granjeno Schist in northeastern Mexico indicates an origin in different tectonic environments: mid-ocean ridge and ocean island. High ratios of Hf/Th and Th/Nb (4.4-14 and 0.08-0.15), low ratios of LaN/YbN and LaN/SmN (0.74-1.7 and 0.60-1.4) and depleted LREE patterns in metabasalt display mid-ocean ridge characteristics. In contrast, the pattern of trace-element ratios and REEs in metabasalt and metapillow lava 60km to the west indicates a magma source with ocean-island basalt characteristics. Both areas were metamorphosed during the Late Carboniferous (300±4Ma). Estimated metamorphic conditions deduced from white mica and chlorite compositions, distinguish greenschist facies (350°C and 4kbar) for the mid-ocean ridge basalt, and prehnite-pumpellyite facies (250°C and 2.5kbar) for the ocean-island-type basalt. This metamorphism took place at an active continental margin during Pennsylvanian time. Our new tectonic model, which differs from earlier models, suggests that the origin of the Granjeno Schist is related to a subduction zone located at the western margin of Pangaea, active after Laurentia-Gondwana collision.
|
|
